BioArctic AB (BRCTF)
20.00
+6.34
(+46.45%)
USD |
OTCM |
Nov 14, 15:33
BioArctic Total Assets (Quarterly): 106.66M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 106.66M |
March 31, 2024 | 106.67M |
December 31, 2023 | 117.82M |
September 30, 2023 | 113.81M |
June 30, 2023 | 100.06M |
March 31, 2023 | 111.55M |
December 31, 2022 | 82.35M |
September 30, 2022 | 81.31M |
June 30, 2022 | 77.76M |
March 31, 2022 | 91.69M |
December 31, 2021 | 99.23M |
September 30, 2021 | 106.36M |
June 30, 2021 | 114.29M |
March 31, 2021 | 115.40M |
December 31, 2020 | 128.26M |
Date | Value |
---|---|
September 30, 2020 | 120.03M |
June 30, 2020 | 117.97M |
March 31, 2020 | 113.95M |
December 31, 2019 | 126.63M |
September 30, 2019 | 126.71M |
June 30, 2019 | 137.60M |
March 31, 2019 | 141.43M |
December 31, 2018 | 155.12M |
September 30, 2018 | 116.17M |
June 30, 2018 | 117.78M |
March 31, 2018 | 132.95M |
December 31, 2017 | 139.46M |
September 30, 2017 | 75.28M |
June 30, 2017 | 75.55M |
December 31, 2016 | 78.09M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
77.76M
Minimum
Jun 2022
128.26M
Maximum
Dec 2020
106.94M
Average
111.55M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
Abliva AB | 7.132M |
Oncopeptides AB | 27.02M |
BioInvent International AB | 107.86M |
Hansa Biopharma AB | 93.30M |
Camurus AB | 353.72M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 19.09M |
Shareholders Equity (Quarterly) | 87.57M |
Current Ratio | 7.177 |